Pirenoxine (International)
Scheme
Rec.INN
CAS registry number (Chemical Abstracts Service)
0001043-21-6
Chemical Formula
C16-H8-N2-O5
Molecular Weight
308
Therapeutic Category
Cataract treatment
Chemical Name
5H-Pyrido[3,2-a]phenoxazine-3-carboxylic acid, 1-hydroxy-5-oxo-
Foreign Names
- Pirenoxinum (Latin)
- Pirenoxin (German)
- Pirénoxine (French)
- Pirenoxina (Spanish)
Generic Names
- Pirenoxine (OS: JAN)
- Pirénoxine (OS: DCF)
- Pirfenoxone (IS)
- Pirenoxine (PH: JP XVII)
Brand Names
- Catalin
Senju, China; Takeda, Egypt - Catalin 0.005%
Senju Seiyaku, Japan - Catalin K 0.005%
Senju Seiyaku, Japan - Clarvisan
Allergan, Italy; Lusomedicamenta, Portugal - Kary Uni
Ferron/Santen, Indonesia; Santen, Philippines; Santen, Thailand; Santen, Taiwan; Santen Pharmaceutical Asia, Singapore; Santen Pharmaceutical China, China - Kary Uni 0.005%
Santen Pharmaceutical, Japan - Pirenoxine 0.005%
Nitto Medic, Japan - Pirenoxine Nitto Medic
Nitto, Taiwan - Catalin
Allergan, India; Helix, Pakistan; PharmaHeads, Poland; Takeda, Hong Kong - Catalin [+ Taurine]
Takeda, Kuwait - Clarvisol
Allergan, Brazil - Kary Uni
Santen, Hong Kong - Pirenoxine Sodium - KeRui Pharm
Kerui Pharmaceutical, China - Pirfalin
Farmigea, Italy; Farmigea, Malta
Glossary
| Term | Definition |
|---|---|
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Further information on drug naming conventions: International Nonproprietary Names.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.